Apotex Health Corp has faced some recent volatility in its stock performance as it continues to navigate the market landscape.
This week, Apotex Health Corp (APTX.TO) saw its stock price decline by 5.90%, closing at C$31.38, down 1.54% on the last trading day. Despite this downturn, the company has been active in the market with several recent developments that could influence investor sentiment moving forward.
Investor takeaway: Investors should keep an eye on Apotex's recent financial results and strategic moves, as these factors may impact its stock performance in the coming weeks. The company's revenue growth and new product approvals could be potential catalysts for future appreciation, despite current price volatility.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.28B
52W high
$40.18
52W low
$26.05
1W change
-5.90%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 29.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.34
+29.7% Upside
Current Price
C$31.87
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
39.7%
Annualized
90-Day Vol
48.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$38.10
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$33.82 | C$29.50 โ C$38.79 |
| 60 trading days | C$35.90 | C$29.58 โ C$43.57 |
| 90 trading days | C$38.10 | C$30.06 โ C$48.30 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$31.38 - Current Stock Price
Despite recent losses, Apotex's stock has gained 15.89% year-to-date, indicating potential resilience in the long term.
Bull case
Apotex has demonstrated strong revenue growth, especially in Canada, and has successfully received Health Canada approval for new products. These achievements can boost market confidence and may drive the stock's performance upward.
Bear case
The latest financial report revealed a significant net loss compared to the previous year, which could raise concerns among investors. Additionally, the stock is currently trading below its moving averages, suggesting a bearish trend.
Recent Price Action
Advertisement
Apotex Health Corp (APTX.TO) experienced a decline of 1.54% on the last trading day, bringing its stock price to C$31.38. Over the past week, the stock has decreased by 5.90%, and it has also seen a drop of 11.91% over the past month. Year-to-date, however, the stock is up by 15.89%, reflecting some resilience despite recent volatility.
Recent Company News
While there were no major news releases directly affecting the stock this week, Apotex Health Corp's recent financial results for Q1 2027 highlighted an 11% revenue growth in Canada, although the company reported a net loss of C$38.3 million, a sharp contrast to a net income of C$362.7 million in the same quarter last year. This mixed performance may influence investor sentiment as the company navigates its growth trajectory.
Technical Picture
From a technical standpoint, Apotex's stock is trading below its 50-day moving average of C$34.99 and its 200-day moving average of C$34.35, indicating a bearish trend. The stock has a 52-week range of C$26.05 to C$40.18, currently sitting at approximately 38% of that range. Recent trading volume has been relatively active, with 72,585 shares changing hands, slightly above the 20-day average volume of 298,184 shares.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
